First Hawaiian Bank lessened its position in Chemed Co. (NYSE:CHE) by 58.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 120 shares of the company’s stock after selling 170 shares during the period. First Hawaiian Bank’s holdings in Chemed were worth $38,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of CHE. Bremer Trust National Association acquired a new position in shares of Chemed in the fourth quarter valued at approximately $25,000. Executive Wealth Management LLC purchased a new stake in Chemed in the fourth quarter valued at approximately $27,000. Financial Gravity Companies Inc. purchased a new stake in Chemed in the fourth quarter valued at approximately $45,000. Enlightenment Research LLC purchased a new stake in Chemed in the fourth quarter valued at approximately $85,000. Finally, Captrust Financial Advisors grew its holdings in Chemed by 32.3% in the fourth quarter. Captrust Financial Advisors now owns 373 shares of the company’s stock valued at $106,000 after purchasing an additional 91 shares during the period. 88.29% of the stock is owned by institutional investors and hedge funds.

Chemed stock opened at $324.45 on Monday. Chemed Co. has a 1 year low of $260.03 and a 1 year high of $335.99. The company has a market capitalization of $5.17 billion, a P/E ratio of 27.20, a P/E/G ratio of 2.87 and a beta of 1.20. The company has a quick ratio of 0.80, a current ratio of 0.83 and a debt-to-equity ratio of 0.15.

Chemed (NYSE:CHE) last released its earnings results on Wednesday, February 20th. The company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.27 by $0.08. Chemed had a net margin of 11.53% and a return on equity of 36.06%. The firm had revenue of $457.51 million during the quarter, compared to the consensus estimate of $460.50 million. During the same period in the previous year, the firm earned $2.32 earnings per share. Chemed’s revenue was up 6.8% compared to the same quarter last year. On average, research analysts predict that Chemed Co. will post 12.77 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, March 22nd. Investors of record on Monday, March 4th were issued a $0.30 dividend. The ex-dividend date was Friday, March 1st. This represents a $1.20 dividend on an annualized basis and a yield of 0.37%. Chemed’s payout ratio is 10.06%.

In related news, insider Kevin J. Mcnamara sold 1,400 shares of the business’s stock in a transaction that occurred on Friday, March 22nd. The shares were sold at an average price of $324.52, for a total value of $454,328.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Michael D. Witzeman sold 735 shares of the business’s stock in a transaction that occurred on Tuesday, March 12th. The shares were sold at an average price of $328.00, for a total transaction of $241,080.00. Following the completion of the sale, the vice president now owns 4,000 shares of the company’s stock, valued at $1,312,000. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 14,599 shares of company stock valued at $4,754,381. 4.82% of the stock is owned by insiders.

CHE has been the subject of a number of recent analyst reports. Royal Bank of Canada boosted their target price on shares of Chemed from $313.00 to $318.00 and gave the company a “sector perform” rating in a report on Monday, February 25th. Zacks Investment Research upgraded shares of Chemed from a “hold” rating to a “buy” rating and set a $310.00 target price for the company in a report on Friday, January 4th.

TRADEMARK VIOLATION NOTICE: This article was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another website, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this article can be viewed at https://www.dailypolitical.com/2019/04/15/first-hawaiian-bank-has-38000-stake-in-chemed-co-che.html.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Read More: Marijuana Stocks Future Looks Bright

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.